Clinical Trial Update: Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial is evaluating sintilimab in combination with the P-GEMOX regimen versus P-GEMOX alone for advanced extranodal natural killer/T-cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• P-GEMOX regimen
• Sintilimab (sintilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | Status: RECRUITING